Auro Laboratories Limited is engaged in pharmaceuticals business. The Company is involved in the business of bulk drugs. It manufactures active pharmaceutical ingredients (APIs), intermediates and generic formulations. It offers APIs under categories, such as antihistamine, including Chlorpheniramine Maleate; muscle relaxant, including Chlorzoxazone; diuretic, including Frusemide; iron deficiency, including Ferrous Fumarate; anti diabetic, including Glibenclamide, Glimepiride and Gliclazide; anti fungal, including Fluconazole, Ketoconazole and Miconazole; iodine supplement, including Potassium Iodate; antacids, including Aluminium Hydroxide Gel and Magnesium Hydroxid; specialty chemicals, including Guanidine Nitrate and 3,4,5, Trimethoxy Benzoic Acid, and others, including Potassium Iodide, Sodium Iodide and Microcrystalline Cellulose. Its products under intermediates include Glibenclamde Sulphonamide, Cis-bramo benzoate, Cls-Tosylate, 2-Ethoxy Benzoic Acid and 5-Bromo Phthalide.